127 related articles for article (PubMed ID: 35094933)
21. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
Lerouge D; Touboul E; Lefranc JP; Uzan S; Jannet D; Moureau-Zabotto L; Genestie C; Antoine M; Jamali M
Cancer Radiother; 2004 Jun; 8(3):168-77. PubMed ID: 15217584
[TBL] [Abstract][Full Text] [Related]
22. Brachytherapy and surgery versus surgery alone for IB2 (FIGO 2018) cervical cancers: A FRANCOGYN study.
Aissaoui O; Phalippou J; Cordoba A; Azais H; Ouldamer L; Bolze PA; Ballester M; Huchon C; Mimoun C; Akladios C; Lecointre L; Raimond E; Graesslin O; Carcopino X; Lavoué V; Bendifallah S; Touboul C; Dabi Y; Canlorbe G; Koskas M; Chauvet P; Collinet P; Kerbage Y
Eur J Obstet Gynecol Reprod Biol; 2023 Nov; 290():128-134. PubMed ID: 37788511
[TBL] [Abstract][Full Text] [Related]
23. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
Toita T; Kato S; Niibe Y; Ohno T; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Tokumaru S; Yamauchi C; Suzuki O; Sakurai H; Numasaki H; Teshima T; Oguchi M; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e49-56. PubMed ID: 21470794
[TBL] [Abstract][Full Text] [Related]
24. Tailored radical hysterectomy for locally advanced cervical cancer.
Sakuragi N; Kaneuchi M; Kato T; Shimada C; Todo Y; Ihira K; Nozaki A; Umazume T; Konno Y; Mitamura T; Kobayashi N; Murakami G; Watari H
Int J Gynecol Cancer; 2020 Aug; 30(8):1136-1142. PubMed ID: 32522774
[TBL] [Abstract][Full Text] [Related]
25. FIGO stage IB1 cervical carcinoma: Place and principles of brachytherapy.
Huertas A; Oldrini S; Nesseler JP; Courrech F; Rétif P; Charra-Brunaud C; Peiffert D
Cancer Radiother; 2017 Apr; 21(2):155-163. PubMed ID: 28233697
[TBL] [Abstract][Full Text] [Related]
26. Minimally invasive radical hysterectomy: an analysis of oncologic outcomes from Hospital Italiano (Argentina).
Odetto D; Puga MC; Saadi J; Noll F; Perrotta M
Int J Gynecol Cancer; 2019 Jun; 29(5):863-868. PubMed ID: 31155517
[TBL] [Abstract][Full Text] [Related]
27. Post-operative radiotherapy in patients with early stage cervical cancer.
Dávila Fajardo R; van Os R; Buist MR; Uitterhoeve L; Westermann AM; Kenter GG; Rasch CR; Stalpers LJ
Gynecol Oncol; 2014 Jul; 134(1):52-9. PubMed ID: 24784874
[TBL] [Abstract][Full Text] [Related]
28. DVH parameters and outcome for patients with early-stage cervical cancer treated with preoperative MRI-based low dose rate brachytherapy followed by surgery.
Haie-Meder C; Chargari C; Rey A; Dumas I; Morice P; Magné N
Radiother Oncol; 2009 Nov; 93(2):316-21. PubMed ID: 19586673
[TBL] [Abstract][Full Text] [Related]
29. Laparoscopic nerve-sparing radical hysterectomy without uterine manipulator for cervical cancer stage IB: description of the technique, our experience and results after the era of LACC trial.
Kavallaris A; Chalvatzas N; Gkoutzioulis A; Zygouris D
Arch Gynecol Obstet; 2021 Apr; 303(4):1039-1047. PubMed ID: 33068159
[TBL] [Abstract][Full Text] [Related]
30. [Stage IB2, IIA and IIB cervical carcinoma without lymph node extension treated with neoadjuvant chemoradiotherapy].
Monnier L; Touboul E; Daraï E; Lefranc JP; Lauratet B; Ballester M; Huguet F
Bull Cancer; 2016 Feb; 103(2):164-72. PubMed ID: 26822905
[TBL] [Abstract][Full Text] [Related]
31. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
[TBL] [Abstract][Full Text] [Related]
32. Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer).
Classe JM; Rauch P; Rodier JF; Morice P; Stoeckle E; Lasry S; Houvenaeghel G;
Gynecol Oncol; 2006 Sep; 102(3):523-9. PubMed ID: 16504274
[TBL] [Abstract][Full Text] [Related]
33. Oncologic results and surgical morbidity of laparoscopic nerve-sparing radical hysterectomy in the treatment of FIGO stage IB cervical cancer: long-term follow-up.
Park NY; Chong GO; Hong DG; Cho YL; Park IS; Lee YS
Int J Gynecol Cancer; 2011 Feb; 21(2):355-62. PubMed ID: 21270616
[TBL] [Abstract][Full Text] [Related]
34. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
[TBL] [Abstract][Full Text] [Related]
35. Comparison of laparoscopic and open radical hysterectomy in cervical cancer patients with tumor size ≤2 cm.
Chen X; Zhao N; Ye P; Chen J; Nan X; Zhao H; Zhou K; Zhang Y; Xue J; Zhou H; Shang H; Zhu H; Leanne VM; Yan X
Int J Gynecol Cancer; 2020 May; 30(5):564-571. PubMed ID: 32276941
[TBL] [Abstract][Full Text] [Related]
36. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX
Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study).
Nakamura K; Kitahara Y; Satoh T; Takei Y; Takano M; Nagao S; Sekiguchi I; Suzuki M
World J Surg Oncol; 2016 Jun; 14(1):173. PubMed ID: 27356862
[TBL] [Abstract][Full Text] [Related]
38. Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery.
Grigsby PW; Perez CA; Chao KS; Elbendary A; Herzog TJ; Rader JS; Mutch DG
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):645-51. PubMed ID: 10524418
[TBL] [Abstract][Full Text] [Related]
39. Pulsed-dose-rate brachytherapy for uterine cervix carcinoma: 10 years of experience with 226 patients at a single institution.
Petit A; Floquet A; Lasbareilles O; Stoeckle E; Chemin A; Kind M; Guyon F; Brouste V; Pigneux J; Thomas L
Brachytherapy; 2013; 12(6):542-9. PubMed ID: 23880416
[TBL] [Abstract][Full Text] [Related]
40. Glassy cell carcinoma of the uterine cervix: 20-year experience from a comprehensive cancer center.
Boustani J; Achkar S; Bertaut A; Genestie C; Gouy S; Pautier P; Morice P; Haie-Meder C; Chargari C
Cancer Radiother; 2021 May; 25(3):207-212. PubMed ID: 33408051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
